Celldex Therapeutics, Inc. (CLDX) stock analysis

CLDX · Celldex Therapeutics, Inc.

Latest recorded price: USD 28.59

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -13.1%, free cash flow margin -13,829.1%. The model flags 2 risk signals for this company (2 high severity).

Similar companies in Healthcare